Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4)

Journal of Urology

Volumn 162, Issue 5, 1999, Pages 1848-1855

  Bivalacqua, Trinity J ^b   Champion, Hunter C ^b   Rajasekaran, Mahadevan ^b   Sikka, Suresh C ^b   Kadowitz, Philip J ^b   Doherty, Paul C ^b   Hellstrom, Wayne J G ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

cAMP; Cavernosal cells; cGMP; PDE inhibitors; Penile erection

Indexed keywords

CYCLIC AMP; MILRINONE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PROSTAGLANDIN E1; ROLIPRAM; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CELL CULTURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG POTENTIATION; ERECTILE DYSFUNCTION; HUMAN; HUMAN CELL; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PENIS ERECTION; PRESSURE; PRIORITY JOURNAL;

EID: 0032845246     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68249-3     Document Type: Article

References (29)

1. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. and McKinlay, J. B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol., 151: 54, 1994.
2. Stief, C. G., Noack, T. and Andersson, K-E.: Signal transduction in cavernous smooth muscle. World J. Urol., 15: 27, 1997.
3. Virag, R.: Intracavernous injection of papaverine for erectile failure. Lancet, 2: 938, 1982.
4. Brindley, G. S.: Cavernosal alpha-blockade: a new technique for investigating and treating erectile dysfunction. Brit. J. Psychioatr., 143: 332, 1983.
5. Burnett, A. L., Lowenestein, C. J., Bredt, D. S., Chang, T. S. K. and Snyder, S. H.: Nitric oxide: a physiologic mediator of penile erction. Science, 257: 401, 1992.
6. Burnett, A. L.: Role of nitric oxide in the physiology of erection. Biol. Reprod., 52: 485, 1995.
7. Lakin, M. M, Montague, D. K., Medendorp, S. V., Tesar, L. and Schover, L. R.: Intracavernous injection therapy: anaylsis of results and complications. J. Urol., 143: 1138, 1990.
8. Beavo, J., Conti, M. and Heaslip, R. J.: Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46: 399, 1994.
9. Dousa, T. P.: Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int., 55: 29, 1999.
10. Taher, A., Meyer, M., Steif, C. G., Jonas, U. and Forssmann, W. G.: Cyclic nucleotide phosphodiesterase in human cavernous smooth muscles. World J. Urol., 15: 32, 1995.
11. Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Osterloh, I. H. and Gingell, C.: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Imp. Res., 8: 47, 1996.
12. Ballard, S., Gingell, C. J., Tang, K., Turner, L. A., Price, M. E. and Naylor, A. M.: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol., 159: 2165, 1998.
13. Chuang, A., Strauss, J. D., Murphy, R. A. and Steers, W. D.: Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J. Urol., 160: 257, 1998.
14. Stief, C. G., Uckert, S., Becker, A. J., Truss, M. C. and Jonas, U.: The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J. Urol., 159: 1390, 1998.
15. Wagner, R., Smith, C. J., Taylor, A. M. and Rhoades, R. A.: Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries. J. Pharmacol. Exp. Ther., 282: 1650, 1997.
16. Gao, Y., Tolsa, J. F., Shen, H. and Usha Raj, J.: Effect of selective phosphodiesterase inhibitors on response of ovine pulmonary arteries to prostaglandin E2. J. Appl. Physiol., 84: 13, 1998.
17. Bivalacqua, T. J., Rajasekaran, M., Champion, H. C., Wang, R., Sikka, S. C., Kadowitz, P. J. and Hellstrom, W. J. G.: The influence of castration on pharmacologically induced penile erection in the cat. J. Androl., 19: 551, 1998.
18. Champion, H. C., Bivalacqua, T. J., Wang, R., Hellstrom, W. J. G. and Kadowitz, P. J.: [Tyr1]-nociceptin and nociceptin have similar naloxone-insensitive erectile activity in the cat. J. Androl., 19: 747, 1998.
19. Wang, R., Domer, F. R., Sikka, S. C., Kadowitz, P. J. and Hellstrom, W. J. G.: Nitric oxide mediates penile erection in cats. J. Urol., 151: 234, 1994.
20. Rajasekaran, M., Mondal, D., Agrawal, K., Chen, I., Hellstrom, W. and Sikka, S.: Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J. Urol., 160: 2210, 1998.
21. Andersson, K-E.: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev., 45: 253, 1993.
22. Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D. and Wicker, P. A.: Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med., 338: 1397, 1998.
23. Moreland, R., Goldstein, I., Kim, N. N. and Traish, A.: Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: research and clinical implications in erectile dysfunction. TEM, 10: 97, 1999.
24. Sparwasser, C., Drescher, P., Will, J. A. and Madsen, P. O.: Smooth muscle tone regulation in rabbit cavernosal spongiosal tissue by cyclic AMP-and cyclic GMP-dependent mechanisms. J. Urol., 152: 2159, 1994.
25. Taher, A., Steif, C. G., Raida, M., Jonas, U. and Forssmann, W. G.: Cyclic nucleotide phosphodiesterase activity in human cavernous smooth muscle and the effect of various selective inhibitors. Int. J. Impotence Res., 4(Suppl. 2): P11, 1992.
26. Kim, Y., Choi, H. K., Ahn, Y. S., Kim, K. H., Hagen, P. O. and Carson, C. C.: The effect of vasoactive intestinal polypeptide (VIP) on rabbit cavernosal smooth muscle contractility. J. Androl., 15: 392, 1994.
27. Miller, M., Morgan, R. J., Thompson, C. S., Mikhailidas, D. P. and Jeremy, J. Y.: Effects of papaverine and vasointestinal polypeptide on penile and vascular cAMP and cGMP in control and diabetic animals: an in vivo study. Int. J. Impot. Res., 7: 91, 1995.
28. Saenz de Tejada, I., Cuevas, P., Fernandez, A., Gabancho, S., Moncada, I., Morales, A. M., Allona, A. and Doherty, P. C.: Differential effects on selective PDE3 and PDE4 inhibition on human penile arteries and trabecular smooth muscle. Int. J. Impotence Res., 10(Suppl. 2): S21, 1998.
29. Morleand, R. B., Traish, A., McMillin, M. A., Smith, B., Goldstein, I. and Saenz de Tejada, I.: PGE1 suppresses the induction of collagen synthesis by transforming growth factor beta-1 in human corpus cavernosum smooth muscle. J. Urol., 153: 826, 1995.